# Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/characterization-and-qualification-of-cell-substrates-and-other-biological-materials-used-in-the-production-of-viral-vaccines-for-infectious-disease-indications-guidance-for-industry/7f4ef6a5-58e5-4416-a8b1-d273185f127f

> FDA guidance document: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications:  Guidance for Industry. Issue date: February 01, 2010. Get complete insights and analysis.

---

## Details

- Title: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2010-02-01
- Last Changed: 2025-02-03
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2006-D-0223">FDA-2006-D-0223</a>

## Related Documents

- [Clinical Considerations for Therapeutic Cancer Vaccines:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-considerations-for-therapeutic-cancer-vaccines-guidance-for-industry/e0e6e4e0-a883-4f71-bf37-784e147d32d9)
- [Cellular Therapy for Cardiac Disease:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/cellular-therapy-for-cardiac-disease-guidance-for-industry/d0a87a21-c69d-46d1-b795-8481faf21a82)
- [Potency Tests for Cellular and Gene Therapy Products:  Final Guidance for Industry:](https://www.globalkeysolutions.net/guidances/guidance-document/potency-tests-for-cellular-and-gene-therapy-products-final-guidance-for-industry/59c72aad-aad2-413a-82eb-440ea6bc25f8)